- Home
- CGEM vs GCI Comparison
CGEM vs GCI Comparison
Compare CGEM & GCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGEM
- GCI
- Stock Information
- Founded
- CGEM 2016
- GCI 1997
- Country
- CGEM United States
- GCI United States
- Employees
- CGEM N/A
- GCI N/A
- Industry
- CGEM Biotechnology: Pharmaceutical Preparations
- GCI Newspapers/Magazines
- Sector
- CGEM Health Care
- GCI Consumer Discretionary
- Exchange
- CGEM Nasdaq
- GCI Nasdaq
- Market Cap
- CGEM 490.3M
- GCI 549.7M
- IPO Year
- CGEM 2021
- GCI N/A
- Fundamental
- Price
- CGEM $7.54
- GCI $3.71
- Analyst Decision
- CGEM Strong Buy
- GCI Buy
- Analyst Count
- CGEM 4
- GCI 3
- Target Price
- CGEM $33.50
- GCI $5.70
- AVG Volume (30 Days)
- CGEM 457.5K
- GCI 2.0M
- Earning Date
- CGEM 05-08-2025
- GCI 05-01-2025
- Dividend Yield
- CGEM N/A
- GCI N/A
- EPS Growth
- CGEM N/A
- GCI N/A
- EPS
- CGEM N/A
- GCI 0.36
- Revenue
- CGEM N/A
- GCI $2,445,127,000.00
- Revenue This Year
- CGEM N/A
- GCI N/A
- Revenue Next Year
- CGEM N/A
- GCI N/A
- P/E Ratio
- CGEM N/A
- GCI $10.33
- Revenue Growth
- CGEM N/A
- GCI N/A
- 52 Week Low
- CGEM $6.85
- GCI $2.55
- 52 Week High
- CGEM $30.19
- GCI $5.93
- Technical
- Relative Strength Index (RSI)
- CGEM 41.51
- GCI 63.51
- Support Level
- CGEM $7.50
- GCI $3.08
- Resistance Level
- CGEM $8.97
- GCI $3.32
- Average True Range (ATR)
- CGEM 0.48
- GCI 0.19
- MACD
- CGEM -0.04
- GCI 0.04
- Stochastic Oscillator
- CGEM 2.72
- GCI 98.68
About CGEM Cullinan Oncology Inc.
Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.
About GCI Gannett Co. Inc.
Gannett Co Inc is a digital newspaper company providing local media and marketing solutions in the U.S. The group operates in three segments, Domestic Gannett Media, Newsquest, and Digital Marketing Solutions. The majority of revenue is from the Domestic Gannett Media segment. The company's brands include USA TODAY and more than 250 daily newspapers as well as digital marketing services companies, including ReachLocal, WordStream, and others. The company produces more than 350 annual events, such as themed expos. The company also operates in the U.K. through the U.K. media company Newsquest, providing more than 150 local media brands.